Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries

Kate Whitfield, Karl-Heinz Huemer, Diana Winter, Steffen Thirstrup, Christian Libersa, Béatrice Barraud, Christine Kubiak, Lea Stankovski, Xina Grählert, Gabriele Dreier, Sebastian Geismann, Wolfgang Kuchinke, Anke Strenge-Hesse, Zsuza Temesvari, Gyorgy Blasko, Gabriella Kardos, Timothy O'Brien, Margaret Cooney, Siobhan Gaynor, Arrigo SchieppatiMariantonia Serrano, Fernando de Andres, Nuria Sanz, Raquel Hernández, Germán Kreis, Charlotte Asker-Hagelberg, Hanna Johansson, Adeeba Asghar, Jean-Marc Husson, Jacques Demotes, Christian Gluud

39 Citationer (Scopus)

Abstract

'Compassionate use' programmes allow medicinal products that are not authorised, but are in the development process, to be made available to patients with a severe disease who have no other satisfactory treatment available to them. We sought to understand how such programmes are regulated in ten European Union countries.
OriginalsprogEngelsk
TidsskriftTrials
Vol/bind11
Sider (fra-til)104
ISSN1745-6215
DOI
StatusUdgivet - 1 jan. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries'. Sammen danner de et unikt fingeraftryk.

Citationsformater